TAK
Takeda Pharmaceutical·NYSE
--
--(--)
--
--(--)
TAK Filings
Filing Date
Form Description
Form Type
2026-01-29
Takeda Pharmaceutical Company Limited (TAK) Q3 2026 Earnings Call Transcript
Earnings Call
2026-01-29 · Earnings Call
Takeda Pharmaceutical Company Limited (TAK) Q3 2026 Earnings Call Transcript
2026-01-29
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Financials
2026-01-29 · Financials
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-12-18
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-12-18 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-12-09
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-12-09 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-12-09
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2025-12-09 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2025-12-09
Form 144 - Report of proposed sale of securities
Ownership
2025-12-09 · Ownership
Form 144 - Report of proposed sale of securities
2025-12-08
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-12-08 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-12-05
Form 144 - Report of proposed sale of securities
Ownership
2025-12-05 · Ownership
Form 144 - Report of proposed sale of securities
2025-12-04
Form 144 - Report of proposed sale of securities
Ownership
2025-12-04 · Ownership
Form 144 - Report of proposed sale of securities
2025-11-28
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-11-28 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
